Long
TomoChain (TOMOUSDT) Bullish Now, Next Target
TomoChain (TOMOUSDT) is now bullish vs TeTherUS (USDT).
Here we have a strong break above all moving averages, EMA10/50/200 and MA200, this is a strong bullish signal.
We also have very high volume with the MACD and RSI allowing for additional growth.
The next targets are marked with magenta dashed lines on the chart.
The yellow marked area is for support.
Above this level, and MA200 (0.4167), TOMOUSDT remains strongly bullish.
Below this level we go bearish.
Remember to hit LIKE for more.
Namaste.
Here we have a strong break above all moving averages, EMA10/50/200 and MA200, this is a strong bullish signal.
We also have very high volume with the MACD and RSI allowing for additional growth.
The next targets are marked with magenta dashed lines on the chart.
The yellow marked area is for support.
Above this level, and MA200 (0.4167), TOMOUSDT remains strongly bullish.
Below this level we go bearish.
Remember to hit LIKE for more.
Namaste.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.